The Animal Auto-Immune Disease Diagnostics Market is estimated to be valued at USD 6.2 billion in 2025 and is projected to reach USD 11.3 billion by 2035, registering a compound annual growth rate (CAGR) of 6.2% over the forecast period.
| Metric | Value |
|---|---|
| Animal Auto-Immune Disease Diagnostics Market Estimated Value in (2025 E) | USD 6.2 billion |
| Animal Auto-Immune Disease Diagnostics Market Forecast Value in (2035 F) | USD 11.3 billion |
| Forecast CAGR (2025 to 2035) | 6.2% |
The Animal Auto-Immune Disease Diagnostics market is experiencing steady growth, driven by the increasing prevalence of auto-immune disorders in both companion and farm animals. Rising awareness among veterinarians and pet owners regarding early detection and management of immune-mediated diseases is supporting market adoption. Advancements in diagnostic technologies, including high-sensitivity immunoassays and molecular testing platforms, are enhancing the accuracy and speed of disease detection, improving clinical outcomes.
The integration of digital tools for laboratory data management and veterinary decision support systems is further accelerating adoption. Growth is also fueled by the rising trend of preventive veterinary care and regular health monitoring, particularly in companion animals. Regulatory focus on animal health, coupled with increased investments in veterinary diagnostics infrastructure, is reinforcing market expansion.
Additionally, the growing emphasis on personalized treatment and targeted therapeutics for animal patients is driving demand for advanced diagnostics As veterinary practices prioritize early and precise identification of auto-immune diseases, the market is poised for sustained growth, supported by technological innovations and increasing veterinary healthcare expenditure globally.
The animal auto-immune disease diagnostics market is segmented by test type, indication, animal type, end user, and geographic regions. By test type, animal auto-immune disease diagnostics market is divided into Immunoassays Test, Complete Blood Count, Thyroid Test, Biopsy Test, Urinalysis, and DNA Amplification Test. In terms of indication, animal auto-immune disease diagnostics market is classified into Auto-Immune Hemolytic Anemia, Hypothyroidism, Pemphigus Disease, Canine Lupus, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Autoimmune Hemolytic Anemia, Immune-Related Arthritis, and Others. Based on animal type, animal auto-immune disease diagnostics market is segmented into Companion Animal, Dogs, Cats, Horse, Live Stock Animal, Cattle, Swine, Poultry, Fish, and Sheep. By end user, animal auto-immune disease diagnostics market is segmented into Veterinary Hospital and Veterinary Clinics. Regionally, the animal auto-immune disease diagnostics industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The immunoassays test segment is projected to hold 24.6% of the market revenue in 2025, establishing it as the leading test type. Growth in this segment is being driven by the high sensitivity and specificity of immunoassay-based diagnostics, which enable accurate detection of auto-immune markers in animals. These tests allow for rapid identification of antibodies or antigens, facilitating early diagnosis and timely intervention.
Immunoassays are compatible with high-throughput workflows and automated laboratory systems, which improves efficiency and reduces operational costs for veterinary clinics and diagnostic laboratories. The reliability and reproducibility of results make immunoassays highly preferred among veterinarians for managing complex immune-mediated conditions.
Continuous advancements in assay chemistry and detection platforms have enhanced diagnostic accuracy and minimized false results As the demand for precise, efficient, and scalable diagnostic solutions grows, immunoassays are expected to maintain their leading position, supported by technological innovation and increasing adoption across veterinary healthcare networks worldwide.
The auto-immune hemolytic anemia indication segment is anticipated to account for 20.1% of the market revenue in 2025, making it the leading indication category. Growth in this segment is being driven by the increasing prevalence of the disease among companion and farm animals, particularly in dogs and cats. Early and accurate detection is critical, as the condition can lead to severe anemia and organ complications if left untreated.
Diagnostic tools that enable rapid identification of hemolytic markers are increasingly being adopted in veterinary clinics and laboratories. Advancements in immunoassays, flow cytometry, and molecular diagnostics have improved sensitivity and specificity, facilitating timely intervention. Veterinary awareness programs, coupled with preventive healthcare trends, are further supporting market growth.
The rising focus on personalized treatment plans and the integration of advanced diagnostics in routine veterinary practice are reinforcing the adoption of tools for managing auto-immune hemolytic anemia As diagnostic capabilities continue to evolve, this indication segment is expected to remain a major contributor to market revenue.
The companion animal segment is projected to hold 29.0% of the market revenue in 2025, establishing it as the leading animal type category. Growth in this segment is driven by the increasing ownership of pets and rising investment in their healthcare. Companion animals, particularly dogs and cats, are more frequently screened for auto-immune disorders due to awareness of early diagnosis and preventive care.
Advanced diagnostic solutions, including immunoassays and molecular testing, are increasingly being adopted in veterinary clinics and diagnostic laboratories to ensure timely and accurate detection of auto-immune conditions. The ability to customize diagnostics and monitor disease progression through repeated testing enhances treatment outcomes and owner satisfaction.
Rising trends in pet insurance coverage, along with increasing disposable income in key markets, are further driving demand The growing focus on companion animal well-being and the importance of early intervention in chronic and complex diseases are expected to sustain the segment’s market leadership in the foreseeable future.
Auto-immune disease is a condition in which the immune system fails to identify body's tissues and begins to attack and reject the as foreign antigen. Some of the popular autoimmune conditions among animal species are autoimmune diseases of the skin such as Pemphigus Vulgaris, Autoimmune hemolytic anemia (AIHA), dry eye, Addison's disease, Canine inflammatory bowel disease, Canine systemic lupus, Rheumatoid Arthritis, Allergies (a hypersensitive immune system) and others.
The diagnosis of autoimmune disease across animal especially among companion animals is performed through absolute measurement of blood panel to analyze the red blood cell, platelet, blood cortisol. These tests are helpful for measuring the presence of positive anti-nuclear antibodies in a blood sample. Veterinarians prescribe urinalysis, thyroid test to diagnose an autoimmune condition in animals. Latest thyroid tests are performed to analyze the presence of T3 (triodothyronine) and T4 (levothyroxine) and other antibodies which indicated auto-immune thyroiditis and other forms of genetic diseases.
| Country | CAGR |
|---|---|
| China | 8.4% |
| India | 7.8% |
| Germany | 7.1% |
| France | 6.5% |
| UK | 5.9% |
| USA | 5.3% |
| Brazil | 4.7% |
The Animal Auto-Immune Disease Diagnostics Market is expected to register a CAGR of 6.2% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 8.4%, followed by India at 7.8%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 4.7%, yet still underscores a broadly positive trajectory for the global Animal Auto-Immune Disease Diagnostics Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 7.1%. The USA Animal Auto-Immune Disease Diagnostics Market is estimated to be valued at USD 2.2 billion in 2025 and is anticipated to reach a valuation of USD 3.6 billion by 2035. Sales are projected to rise at a CAGR of 5.3% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 318.3 million and USD 164.9 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 6.2 Billion |
| Test Type | Immunoassays Test, Complete Blood Count, Thyroid Test, Biopsy Test, Urinalysis, and DNA Amplification Test |
| Indication | Auto-Immune Hemolytic Anemia, Hypothyroidism, Pemphigus Disease, Canine Lupus, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Autoimmune Hemolytic Anemia, Immune-Related Arthritis, and Others |
| Animal Type | Companion Animal, Dogs, Cats, Horse, Live Stock Animal, Cattle, Swine, Poultry, Fish, and Sheep |
| End User | Veterinary Hospital and Veterinary Clinics |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter Inc., Thermo Fisher Scientific, Quest Diagnostics, Bio-Rad laboratories, Inova Diagnostics, Crescendo Bioscience, SQI Diagnostics, EUROMMIUM AG, Progentec, and Hemagem Diagnostics |
The global animal auto-immune disease diagnostics market is estimated to be valued at USD 6.2 billion in 2025.
The market size for the animal auto-immune disease diagnostics market is projected to reach USD 11.3 billion by 2035.
The animal auto-immune disease diagnostics market is expected to grow at a 6.2% CAGR between 2025 and 2035.
The key product types in animal auto-immune disease diagnostics market are immunoassays test, complete blood count, thyroid test, biopsy test, urinalysis and DNA amplification test.
In terms of indication, auto-immune hemolytic anemia segment to command 20.1% share in the animal auto-immune disease diagnostics market in 2025.
Explore Similar Insights
Animal Auto-Immune Disease Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
